Anzeige
Mehr »
Login
Donnerstag, 14.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Investment in die Zukunft: Absoluter Geheimtipp - diese Aktie beschleunigt deine Renditechancen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PBJC | ISIN: US03837C1062 | Ticker-Symbol: BOV
Stuttgart
14.11.24
08:21 Uhr
1,250 Euro
-0,010
-0,79 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
APYX MEDICAL CORPORATION Chart 1 Jahr
5-Tage-Chart
APYX MEDICAL CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
1,1801,26019:47
1,2001,25019:47

Aktuelle News zur APYX MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
APYX MEDICAL Aktie jetzt für 0€ handeln
FrApyx Medical Corp - 10-Q, Quarterly Report-
FrApyx Medical secures $7 million in direct offering1
FrApyx Medical sichert sich 7 Millionen US-Dollar durch Direktplatzierung5
FrApyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering1
FrApyx Medical GAAP EPS of -$0.14, revenue of $11.5M1
FrApyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook99Strengthened balance sheet with a common stock registered direct offering with gross proceeds of approximately $7.0 million; and amended revenue covenants for the Company's credit agreement with PerceptiveAnnounces...
► Artikel lesen
FrApyx Medical Corp - 8-K, Current Report-
07.11.A Look Ahead: Apyx Medical's Earnings Forecast5
25.10.Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 20242
16.10.BTIG setzt neutrales Rating für Apyx Medical aufgrund des Marktpotenzials3
16.10.Neutral rating set for Apyx Medical by BTIG on market potential1
14.08.Apyx medical CFO acquires $6k in company stock1
12.08.Apyx Medical Corp - 8-K, Current Report1
12.08.Earnings call: Apyx Medical reports mixed Q2 results amid market challenges1
08.08.Apyx Medical Corp - 10-Q, Quarterly Report1
08.08.Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook88CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform technology...
► Artikel lesen
09.05.Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook197CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed...
► Artikel lesen
21.03.Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook170CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed...
► Artikel lesen
08.01.Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results159CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1